Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446453 ((R)-1-((7-cyano-2-(3′-(7-(((R)-3-hydroxypyrr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <10 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446473 ((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <10 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446478 ((S)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <10 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446477 ((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <10 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446463 ((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <10 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446481 ((R)-1-((7-cyano-2-(3′-(6-(difluoromethyl)-3-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <10 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446470 ((S)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <10 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446456 ((R)-1-((7-cyano-2-(3′-(7-(((S)-1-hydroxyprop...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446457 ((R)-1-((7-cyano-2-(3′-(7-(((S)-2-hydroxyprop...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446458 ((R)-1-((7-cyano-2-(3′-(7-(((R)-3-hydroxypyrr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446459 ((R)-1-((7-cyano-2-(3′-(7-(((R)-3-hydroxy-3-m...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446460 ((R)-1-((7-cyano-2-(3′-(7-(((S)-3-hydroxy-3-m...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446461 ((R)-1-((7-cyano-2-(3′-(7-(((S)-1-hydroxyprop...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446462 ((R)-1-((7-cyano-2-(3′-(7-(((S)-2-hydroxyprop...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446464 ((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446465 ((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446463 ((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446464 ((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446465 ((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446469 ((S)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446471 ((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446472 ((R)-1-((7-cyano-2-(3′-(2-(difluoromethyl)-7-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446474 ((R)-3-(1-((7-cyano-2-(3′-(2-(difluoromethyl)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446475 ((R)-1-((7-cyano-2-(3′-(2-cyclopropyl-7-(((R)...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446476 ((R)-1-((2-(3′-(2-amino-7-((3-hydroxypyrrolid...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446479 ((R)-1-((7-cyano-2-(3′-(2-(hydroxymethyl)-7-(...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446455 ((R)-1-((7-cyano-2-(3′-(7-(((S)-3-hydroxy-3-m...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446454 ((R)-1-((7-cyano-2-(3′-(7-(((R)-3-hydroxy-3-m...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446453 ((R)-1-((7-cyano-2-(3′-(7-(((R)-3-hydroxypyrr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446452 ((S)-1-((7-cyano-2-(3′-(7-((2-hydroxypropylam...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446451 ((S)-1-((7-cyano-2-(3′-(7-((1-hydroxypropan-2...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446450 ((S)-1-((7-cyano-2-(3′-(7-((3-hydroxy-3-methy...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446448 ((R)-1-((7-cyano-2-(3′-(7-((3-hydroxypyrrolid...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM446449 ((R)-1-((7-cyano-2-(3′-(7-((3-hydroxy-3-methy...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 55 | n/a | n/a | n/a | n/a |
Incyte Corporation US Patent | Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418... | US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM50427507 (CHEMBL2322546) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a |
Universit£ degli Studi di Padova Curated by ChEMBL | Assay Description Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ... | J Med Chem 56: 1830-42 (2013) Article DOI: 10.1021/jm3009647 BindingDB Entry DOI: 10.7270/Q2TH8P10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM50427536 (CHEMBL2322281) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a |
Universit£ degli Studi di Padova Curated by ChEMBL | Assay Description Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ... | J Med Chem 56: 1830-42 (2013) Article DOI: 10.1021/jm3009647 BindingDB Entry DOI: 10.7270/Q2TH8P10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM50427539 (CHEMBL2322278) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a |
Universit£ degli Studi di Padova Curated by ChEMBL | Assay Description Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ... | J Med Chem 56: 1830-42 (2013) Article DOI: 10.1021/jm3009647 BindingDB Entry DOI: 10.7270/Q2TH8P10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM50331546 (2-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)benzenes...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Universit£ degli Studi di Padova Curated by ChEMBL | Assay Description Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ... | J Med Chem 56: 1830-42 (2013) Article DOI: 10.1021/jm3009647 BindingDB Entry DOI: 10.7270/Q2TH8P10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM50427547 (CHEMBL2322270) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 4.00E+4 | n/a | n/a | n/a | n/a |
Universit£ degli Studi di Padova Curated by ChEMBL | Assay Description Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ... | J Med Chem 56: 1830-42 (2013) Article DOI: 10.1021/jm3009647 BindingDB Entry DOI: 10.7270/Q2TH8P10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM50427550 (CHEMBL2322267) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 4.00E+4 | n/a | n/a | n/a | n/a |
Universit£ degli Studi di Padova Curated by ChEMBL | Assay Description Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ... | J Med Chem 56: 1830-42 (2013) Article DOI: 10.1021/jm3009647 BindingDB Entry DOI: 10.7270/Q2TH8P10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM50427513 (PYROCATECHOL VIOLET) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Universit£ degli Studi di Padova Curated by ChEMBL | Assay Description Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ... | J Med Chem 56: 1830-42 (2013) Article DOI: 10.1021/jm3009647 BindingDB Entry DOI: 10.7270/Q2TH8P10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM50427512 (AURIN | CI-43800 | Corallin | Rosolic acid | Rosol...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase MCE KEGG PC cid PC sid UniChem | Article PubMed | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Universit£ degli Studi di Padova Curated by ChEMBL | Assay Description Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ... | J Med Chem 56: 1830-42 (2013) Article DOI: 10.1021/jm3009647 BindingDB Entry DOI: 10.7270/Q2TH8P10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM50427502 (CHEMBL2321884) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 6.00E+4 | n/a | n/a | n/a | n/a |
Universit£ degli Studi di Padova Curated by ChEMBL | Assay Description Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ... | J Med Chem 56: 1830-42 (2013) Article DOI: 10.1021/jm3009647 BindingDB Entry DOI: 10.7270/Q2TH8P10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM50427497 (CHEMBL2322555) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 6.00E+4 | n/a | n/a | n/a | n/a |
Universit£ degli Studi di Padova Curated by ChEMBL | Assay Description Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ... | J Med Chem 56: 1830-42 (2013) Article DOI: 10.1021/jm3009647 BindingDB Entry DOI: 10.7270/Q2TH8P10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM50427494 (CHEMBL2322558) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 6.00E+4 | n/a | n/a | n/a | n/a |
Universit£ degli Studi di Padova Curated by ChEMBL | Assay Description Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ... | J Med Chem 56: 1830-42 (2013) Article DOI: 10.1021/jm3009647 BindingDB Entry DOI: 10.7270/Q2TH8P10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM50427542 (CHEMBL2322275) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 6.00E+4 | n/a | n/a | n/a | n/a |
Universit£ degli Studi di Padova Curated by ChEMBL | Assay Description Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ... | J Med Chem 56: 1830-42 (2013) Article DOI: 10.1021/jm3009647 BindingDB Entry DOI: 10.7270/Q2TH8P10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM50427531 (CHEMBL2322252) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 6.00E+4 | n/a | n/a | n/a | n/a |
Universit£ degli Studi di Padova Curated by ChEMBL | Assay Description Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ... | J Med Chem 56: 1830-42 (2013) Article DOI: 10.1021/jm3009647 BindingDB Entry DOI: 10.7270/Q2TH8P10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM50427501 (CHEMBL2322551) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 6.00E+4 | n/a | n/a | n/a | n/a |
Universit£ degli Studi di Padova Curated by ChEMBL | Assay Description Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ... | J Med Chem 56: 1830-42 (2013) Article DOI: 10.1021/jm3009647 BindingDB Entry DOI: 10.7270/Q2TH8P10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM50427503 (CHEMBL2322550) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 6.00E+4 | n/a | n/a | n/a | n/a |
Universit£ degli Studi di Padova Curated by ChEMBL | Assay Description Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ... | J Med Chem 56: 1830-42 (2013) Article DOI: 10.1021/jm3009647 BindingDB Entry DOI: 10.7270/Q2TH8P10 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human)) | BDBM50427534 (CHEMBL2322283) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 7.00E+4 | n/a | n/a | n/a | n/a |
Universit£ degli Studi di Padova Curated by ChEMBL | Assay Description Inhibition of human NF-kappaB p50/DNA interaction using 32P-labeled oligonucleotides as substrate preincubated for 20 mins before substrate addition ... | J Med Chem 56: 1830-42 (2013) Article DOI: 10.1021/jm3009647 BindingDB Entry DOI: 10.7270/Q2TH8P10 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 92 total ) | Next | Last >> |